Carrington Laboratories Announces Distribution Agreement With Darrow Laboratorios of Brazil.IRVING, Texas--(BUSINESS WIRE)--Dec. 5, 1996--Carrington Laboratories, Inc, (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CARN) has granted exclusive distribution rights for its wound care, diabetic and radiation product lines to Darrow Laboratorios, S.A. of Rio de Janeiro Rio de Janeiro, city, Brazil Rio de Janeiro (rē`ō də zhänā`rō, Port. rē`  thĭ zhənĕē`r , Brazil. Darrow Laboratorios is one of the largest nationally-owned pharmaceutical companies in Brazil, a nation with a population of more than 150 million and an annual gross national product estimated at more than $600 billion. Darrow Laboratorios is a successful niche marketer in Brazil focused on hospital, medical office, and retail markets. With more than $35 million annually in sales, Darrow Laboratorios has a sales force of approximately 90 representatives in a pharmaceutical market estimated at $8 billion annually. Under the agreement, Carrington is licensing its proprietary wound care products to Darrow for distribution. In return, Darrow will register Carrington's products for sale and use in the Brazilian market. In anticipation of the agreement, Darrow began the registration process in Brazil in September. Products are expected to begin shipping during the first half of 1997. Commenting on the agreement, Luiz Cerqueira, Carrington vice president of operations/manufacturing and Latin American sales, said, "The addition of the Brazilian healthcare market to other new sales efforts in Canada, Mexico, Australia, New Zealand New Zealand (zē`lənd), island country (2005 est. pop. 4,035,000), 104,454 sq mi (270,534 sq km), in the S Pacific Ocean, over 1,000 mi (1,600 km) SE of Australia. The capital is Wellington; the largest city and leading port is Auckland. and in the Pacific Rim Pacific Rim, term used to describe the nations bordering the Pacific Ocean and the island countries situated in it. In the post–World War II era, the Pacific Rim has become an increasingly important and interconnected economic region. brings exciting new dynamics to Carrington. Entering the Brazilian healthcare market today is as exciting as Carrington's initial entry into the U.S. wound care market 12 years ago." Nelson Duarte Jr. president of Darrow Laboratorios, said, "We are pleased to be partnering with Carrington Laboratories in this exciting new venture. We know the reputation Carrington enjoys for the management of wounds and look forward to bringing these quality products home to our Brazilian consumers. We are especially pleased to be introducing Carrasyn(R), the number one selling hydrogel hy·dro·gel n. A colloidal gel in which the particles are dispersed in water. hydrogel a gel that contains water. hydrogel Wound care A polymer absorptive wound dressing. See Dressing. in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , to the Brazilian market." The statements about this marketing agreement are forward-looking. Actual impact on the company will be dependent upon a number of factors and is subject to a variety of risks including but not limited to the following: subsequent changes in plans by the company's management; delays or problems in product development; changes in industry trends; actions of the company's competitors; regulatory issues; and a number of other factors and risks described from time to time in the company's reports filed with the Securities & Exchange Commission, including the Form 10-Q Form 10-Q See 10-Q. for the quarter ended Sept. 30, 1996. Carrington Laboratories, Inc., is an emerging research-based pharmaceutical and medical device company engaged in developing complex carbohydrate-based therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. and oral technology products, and in manufacturing and marketing products for the management of wounds. Carrington currently has more than 50 products on the market. CONTACT: Carrington Laboratories, Jim Blackmore, APR APR See: Annual Percentage Rate 972/714-5046 or 800/471-8817 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion